ArticleJAMA network open2025
Trends in Daily Nicotine Vaping and Unsuccessful Quit Attempts in Youths.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Noninvasive repeated sampling technique reveals specific respiratory cytokine signatures for people who use electronic-cigarette and dual-products obtained from a remote cohort of young adults.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Article
- Long-term health risks of e-cigarettes after smoking cessation.Nature medicine · 2026Article
- Emerging multisystem disease mechanisms of e-cigarette vaping on human health.Toxicology reports · 2026Review
- Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers.Cell · 2026Review
- E-Cigarette Use Trajectories and Respiratory Symptoms in Adolescents and Young Adults: Sustained Use Linked to Greater Symptom Frequency.Journal of studies on alcohol and drugs · 2026Article
- Predictors of vaping relapse based on e-cigarette use measures: A secondary analysis of longitudinal data from the 'Stop Vaping Challenge' cessation application.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Importance: US youths who vape nicotine may be hardening into a more nicotine-dependent, treatment-resistant population over time, as evidenced by shifts toward daily vaping and difficulty quitting, which may vary by behavioral health and demographic factors. Objective: To assess prevalence trends from 2020 to 2024 in (1) current (past 30 days) nicotine vaping, (2) daily vaping among youths who currently vape nicotine, and (3) unsuccessful quit attempts among youths who vape nicotine daily and to examine variation in these trends by behavioral health and demographic factors. Design, Setting, and Participants: This cross-sectional study used data from Monitoring the Future (MTF), a nationally representative annual cross-sectional survey of 8th, 10th, and 12th grade respondents in US middle and high schools, from survey years 2020 to 2024. Exposures: Survey year; grade in school; population density of school location; and self-reported sex, race and ethnicity, depressive symptoms, conduct problems, and past-30-day use of nicotine vaping, other tobacco products, cannabis, and alcohol. Main Outcomes and Measures: Prevalence of (1) past-30-day nicotine vaping (≥1 vs 0 days) among all respondents, (2) past-30-day daily vaping among currently vaping youths (vaped all 30 vs 1-29 days), and (3) unsuccessful attempts to quit vaping (yes, no) among youths vaping daily, with weights applied to generate nationally representative estimates. Results: In the pooled sample of 115 191 MTF respondents (50.8% [95% CI, 50.0%-51.6%] male), prevalence of past-30-day nicotine vaping declined from 2020 to 2024 (risk ratio [RR], 0.88; 95% CI, 0.86-0.89). Among youths who currently vaped (n = 15 226), prevalence of daily vaping rose from 15.4% (95% CI, 13.1%-18.0%) in 2020 to 28.8% (95% CI, 26.6%-31.0%) in 2024 (RR, 1.14; 95% CI, 1.11-1.18). Among daily vapers (n = 3512), prevalence of unsuccessful quit attempts increased from 28.2% (95% CI, 19.5%-38.8%) in 2020 to 53.0% (95% CI, 45.9%-60.0%) in 2024 (RR, 1.08; 95% CI, 1.02-1.15). For female, non-Hispanic Black, cannabis-using, and tobacco-using youths, past-30-day nicotine vaping prevalence either remained stable or reduced more slowly during 2020 to 2024 compared with the overall study population (eg, from 10.4% [95% CI, 8.6%-12.5%] to 4.1% [95% CI, 3.5%-4.8%] in those without vs 58.1% [95% CI, 51.9%-64.1%] to 57.3% [95% CI, 54.0%-60.5%] in those with past-30-day cannabis use). Among current vapers, daily vaping increased more rapidly in rural youths (from 16.4% [95% CI, 11.5%-22.9%] to 41.8% [95% CI, 35.3%-48.5%]) than in urban youths (15.9% [95% CI, 12.7%-19.6%] to 18.1% [95% CI, 14.8%-21.9%]). Conclusions and Relevance: The findings of this cross-sectional study of US youths suggest that although the prevalence of current nicotine vaping declined during 2020 to 2024, the youth vaping population may have hardened over this period, evidenced by increasing daily use, more unsuccessful quit attempts, and shifting demographic profiles. Clinicians and policy makers should be mindful that youths with frequent vaping increasingly face unique challenges that may impact treatment and prevention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.